ACTION POTENTIAL VENTURE CAPITAL LIMITED
🌳Matureactive
08603529 · ltd · incorporated 2013-07-10
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
- · Thesis: well-run, low negotiation leverage
🔒Estimated value
—
Upgrade to see
Turnover
—
not disclosed
Net worth
—
book net assets
Opportunity
79/100
Strong
What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
PursueStrong opportunity: active trading company with strong profile and bankable structure.
Opportunity 79/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: medium (60/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
9 officers (5 active, 9 linked, 6 with DOB)
83
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
26 connected companies via shared directors
90
Filing history
49 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
79/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
70
Active, clean filings, stable charge profile.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Recent activity
Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
- • 1 officers
Counts from Companies House filing history.
Corporate timeline (33 events)Click to expand
- 2026-01-06📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-12-31➖LYNCH, Ciara Martha resigneddirector
- 2025-09-30📄accounts-with-accounts-type-fullaccounts · AA
- 2025-07-04📄change-person-director-company-with-change-dateofficers · CH01
- 2024-09-23📄change-person-director-company-with-change-dateofficers · CH01
- 2024-09-17📄change-person-director-company-with-change-dateofficers · CH01
- 2024-09-17📄change-person-director-company-with-change-dateofficers · CH01
- 2024-09-11📄change-corporate-director-company-with-change-dateofficers · CH02
- 2024-07-18📍change-sail-address-company-with-old-address-new-addressaddress · AD02
- 2024-07-16📄accounts-with-accounts-type-fullaccounts · AA
- 2023-08-16📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2023-08-16📄change-corporate-director-company-with-change-dateofficers · CH02
- 2023-06-30📄accounts-with-accounts-type-fullaccounts · AA
- 2023-06-09📍change-sail-address-company-with-new-addressaddress · AD02
- 2023-06-06📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-08-03📄accounts-with-accounts-type-fullaccounts · AA
- 2022-06-06📄resolutionresolution · RESOLUTIONS
- 2022-06-06📄memorandum-articlesincorporation · MA
- 2021-11-29📄accounts-with-accounts-type-fullaccounts · AA
- 2020-10-16📄accounts-with-accounts-type-fullaccounts · AA
- 2020-03-02➕LYNCH, Ciara Martha appointeddirector
- 2020-03-02➖PANAGIOTIDIS, Charalampos resigneddirector
- 2019-05-31➖ECKSTEIN, Jens, Dr resigneddirector
- 2019-04-26➕WILLIAMS, Subesh Ronald appointeddirector
- 2019-02-15➕PANAGIOTIDIS, Charalampos appointeddirector
- 2016-03-01➖BLACKBURN, Paul Frederick resigneddirector
- 2015-06-03➕WALKER, Adam appointeddirector
- 2013-09-10➕ECKSTEIN, Jens, Dr appointeddirector
- 2013-07-10🏢Company incorporatedAs ACTION POTENTIAL VENTURE CAPITAL LIMITED
- 2013-07-10➕EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED appointedcorporate-secretary
- 2013-07-10➕GLAXO GROUP LIMITED appointedcorporate-director
- 2013-07-10➕THE WELLCOME FOUNDATION LIMITED appointedcorporate-director
- 2013-07-10➕BLACKBURN, Paul Frederick appointeddirector
Owner dependency
71/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- -4 active directors: Broader management team in place — suggests transferable governance.
- +Founder name in company name: Company name contains director surname "LIMITED" — strong identity link between founder and business.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
63/100
Strong succession signalMultiple signals suggest succession is on the horizon. Candidate for proactive outreach.
SIGNALS
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
- secondary12+ year tenure: Director in role 13 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Group structure
Glaxo Group Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
🏛️ultimate parent
Glaxo Group Limited
Corporate parent · holds 75-100% shares · board control
⬇
ACTION POTENTIAL VENTURE CAPITAL LIMITED
This company · 08603529
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Glaxo Group Limited Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · SG postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALLIED ACCOUNTANCY LIMITED→ 10708117 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| ALPAC ADVISORY LIMITED→ 11306032 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ALPINE RESORT NANNIES LTD→ 11341309 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AMBER RECLAIM LTD→ 16663660 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMBR LTD→ 12971824 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AML COMPLIANCE EXPERTS LIMITED→ 16293777 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AMPYR IDEA UK LTD→ 15255740 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMRT CONSULTING LTD→ 16936223 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMWELL SPRING CONSULTING LIMITED→ 12213181 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMY TAYLOR ACCOUNTANCY LIMITED→ 08300970 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ANDREW HILLIER CONSULTING LIMITED→ 07935015 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| ANDREW NUNN LIMITED→ 17122944 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2013-07-10
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology
Registered office
Gsk Medicines Research Centre
Gunnels Wood Road
Stevenage
SG1 2NY
United Kingdom
Filing status
Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2026-10-13
Last: 2025-09-29
Officers (5 active · 4 resigned)
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED→
Activecorporate-secretary · appointed 2013-07-10
View their other companies + combined net worth →
WALKER, Adam→
Activedirector · ~59y · appointed 2015-06-03
View their other companies + combined net worth →
WILLIAMS, Subesh Ronald→
Activedirector · ~64y · appointed 2019-04-26
View their other companies + combined net worth →
GLAXO GROUP LIMITED→
Activecorporate-director · appointed 2013-07-10
View their other companies + combined net worth →
THE WELLCOME FOUNDATION LIMITED→
Activecorporate-director · appointed 2013-07-10
View their other companies + combined net worth →
BLACKBURN, Paul Frederick→
Resigneddirector · ~72y · appointed 2013-07-10 · resigned 2016-03-01
ECKSTEIN, Jens, Dr→
Resigneddirector · ~63y · appointed 2013-09-10 · resigned 2019-05-31
LYNCH, Ciara Martha→
Resigneddirector · ~58y · appointed 2020-03-02 · resigned 2025-12-31
PANAGIOTIDIS, Charalampos→
Resigneddirector · ~49y · appointed 2019-02-15 · resigned 2020-03-02
Click a director name to see their full track record across all companies.
Recent filings (49 total)
termination-director-company-with-name-termination-date
officers · TM01
2026-01-06
accounts-with-accounts-type-full
accounts · AA
2025-09-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-09-29
change-person-director-company-with-change-date
officers · CH01
2025-07-04
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-10-28
change-person-director-company-with-change-date
officers · CH01
2024-09-23
change-person-director-company-with-change-date
officers · CH01
2024-09-17
change-person-director-company-with-change-date
officers · CH01
2024-09-17
change-corporate-director-company-with-change-date
officers · CH02
2024-09-11
change-sail-address-company-with-old-address-new-address
address · AD02
2024-07-18
accounts-with-accounts-type-full
accounts · AA
2024-07-16
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-10-25
change-to-a-person-with-significant-control
persons-with-significant-control · PSC05
2023-08-16
change-corporate-director-company-with-change-date
officers · CH02
2023-08-16
accounts-with-accounts-type-full
accounts · AA
2023-06-30